These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 518555)

  • 21. A bisubstrate analog inhibitor for alpha(1----2)-fucosyltransferase.
    Palcic MM; Heerze LD; Srivastava OP; Hindsgaul O
    J Biol Chem; 1989 Oct; 264(29):17174-81. PubMed ID: 2551897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-associated elevation of alpha(1----3)-L-fucosyltransferase activity in human serum.
    Yazawa S; Madiyalakan R; Izawa H; Asao T; Furukawa K; Matta KL
    Cancer; 1988 Aug; 62(3):516-20. PubMed ID: 3390792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical modifications of alpha1,6-fucosyltransferase define amino acid residues of catalytic importance.
    Kamińska J; Wiśniewska A; Kościelak J
    Biochimie; 2003; 85(3-4):303-10. PubMed ID: 12770769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum fucosyltransferase activity in malignant diseases].
    Kuzmits R; Aiginger P; Kühböck J
    Acta Med Austriaca Suppl; 1979; 6():349-51. PubMed ID: 299229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participation of an endogenous inhibitor of fucosyltransferase activities in the developmental regulation of intestinal fucosylation processes.
    Ruggiero-Lopez D; Biol MC; Louisot P; Martin A
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):801-6. PubMed ID: 1953674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the fucosyltransferase system in intestinal microsomes.
    Martin A; Biol MC; Broquet P; Richard M; Louisot P
    Enzyme; 1988; 39(1):17-27. PubMed ID: 3345733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dictyostelium cytosolic fucosyltransferase synthesizes H type 1 trisaccharide in vitro.
    Trinchera M; Bozzaro S
    FEBS Lett; 1996 Oct; 395(1):68-72. PubMed ID: 8849691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fucosyltransferase activities in human lymphocytes and granulocytes. Blood group H-gene-specified alpha-2-L-fucosyltransferase is a discriminatory marker of peripheral blood lymphocytes.
    Greenwell P; Ball MG; Watkins WM
    FEBS Lett; 1983 Dec; 164(2):314-7. PubMed ID: 6681413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrofocusing patterns of fucosyltransferases in plasma of patients with neoplastic disease.
    Kessel D; Ratanatharathorn V; Chou TH
    Cancer Res; 1979 Sep; 39(9):3377-80. PubMed ID: 89896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three different endogenous alpha-L-fucosyltransferases expressed in COS cells.
    Clarke JL; Watkins WM
    Biochem Biophys Res Commun; 1997 Aug; 237(2):400-6. PubMed ID: 9268723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human salivary fucosyltransferases : evidence for two distinct alpha-3-L-fucosyltransferase activities one or which is associated with the Lewis blood group Le gene.
    Johnson PH; Yates AD; Watkins WM
    Biochem Biophys Res Commun; 1981 Jun; 100(4):1611-8. PubMed ID: 7295318
    [No Abstract]   [Full Text] [Related]  

  • 32. Significance of altered alpha-2-L-fucosyltransferase levels in serum of leukemic patients.
    Skacel PO; Watkins WM
    Cancer Res; 1988 Jul; 48(14):3998-4001. PubMed ID: 3164255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of two plasma fucosyltransferases as marker enzymes in non-Hodgkin's lymphoma.
    Khilanani P; Chou TH; Ratanatharathorn V; Kessel D
    Cancer; 1978 Feb; 41(2):701-5. PubMed ID: 343912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell adhesion mediated by a purified fucosyltransferase.
    Rauvala H; Prieels JP; Finne J
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3991-5. PubMed ID: 6575391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fucosyltransferases produce N-glycans containing core l-galactose.
    Ohashi H; Ohashi T; Kajiura H; Misaki R; Kitamura S; Fujiyama K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):658-663. PubMed ID: 27993676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of fucosyltransferase and fucosidase inhibitors.
    Tu Z; Lin YN; Lin CH
    Chem Soc Rev; 2013 May; 42(10):4459-75. PubMed ID: 23588106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate specificity of fucosyltransferase purified from human parotid saliva.
    Tamagawa H; Iwakura K; Amano A; Shizukuishi S; Tsunemitsu A
    J Dent Res; 1987 Mar; 66(3):756-60. PubMed ID: 2440923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and some properties of fucosyltransferase in human parotid saliva.
    Tamagawa H; Inoshita E; Takeshita T; Takagaki M; Shizukuishi S; Tsunemitsu A
    J Dent Res; 1987 Jan; 66(1):72-7. PubMed ID: 3476546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical modification of alpha(1-3) fucosyltransferase defines residues of catalytic importance.
    Britten C; Hood C; Bird M
    Biochem Soc Trans; 1995 May; 23(2):166S. PubMed ID: 7672192
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of N-acetyl-2'-O-methyllactosamine as a specific acceptor for the determination of alpha-L-(1----3)-fucosyltransferase in human serum.
    Madiyalakan R; Yazawa S; Abbas SA; Barlow JJ; Matta KL
    Anal Biochem; 1986 Jan; 152(1):22-8. PubMed ID: 3954042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.